Results 91 to 100 of about 1,438,673 (245)

Features of encephalopathy diagnosis in patients with portal hypertension syndrome

Gastroenterologìa, 2017
Background. Hepatic encephalopathy is a pathological change in the brain functions of non-inflammatory origin, which is manifested by a syndrome of secondary neurological and cognitive disorders caused by a set of deep metabolic disorders, as a result of
Yu.M. Stepanov, N.V. Chaliy, S.L. Меlanich   +2 more
doaj   +1 more source

Critical Flicker Frequency is Diagnostic of Minimal Hepatic Encephalopathy

, 2017
Minimal hepatic encephalopathy may affect up to 80% of cirrhotic patients, in the absence of overt hepatic encephalopathy. The objective of the study is to evaluate the accuracy of diagnosis of minimal hepatic encephalopathy with critical flicker ...
Nouman El Garem, Mohamed Elfekki, Serag Esmat, Gihan A Sleem, Hassan Raslan   +4 more
core   +1 more source

Disease of South American camelids in England and Wales: Analysis of diagnoses from Animal and Plant Health Agency laboratory submissions between 2012 and 2021

Veterinary Record, EarlyView.
Abstract Background South American camelids (SACs) have become increasingly popular in the UK. Consequently, knowledge among veterinary practitioners about diseases in these non‐native species has improved, although gaps remain. The remit of this study was to identify common diseases of SACs based on Animal and Plant Health Agency (APHA) surveillance ...
Sonja Jeckel, Carissa Xian Chow, David Jorge   +2 more
wiley   +1 more source

Evaluation of the prevalence of minimal hepatic encephalopathy in patients with compensated cirrhosis [PDF]

, 2010
In this study 50 cases of compensated cirrhotics were evaluated for presence of Minimal Hepatic Encephalopathy. • In this study we defined minimal hepatic encephalopathy based on psychometric analysis,13 by way of the Number Connection Test, since ...
Yoganandh, T
core  

Risk factors associated with the diagnosis of minimal hepatic encephalopathy as defined by the psychometric hepatic encephalopathy score.

, 2015
Education level: 0(0–6), 1(7–12), 2(over 12 years)Age: 0(20–29), 1(30–39), 2(40–49), 3(50–59), 4(60–69), 5 (over 70 years)Child-Pugh: 0(A), 1(B), 2(C)Risk factors associated with the diagnosis of minimal hepatic encephalopathy as defined by the ...
Ching-Liang Lu (404817), Pei-Yi Liu (748999), Yi-Hsiang Huang (115190), Fa-Yauh Lee (115194), Chia-Fen Tsai (398472), Yen-Po Wang (634471), Chi-Jen Chu (748998), Han-Chieh Lin (115193)   +7 more
core   +1 more source

Prognostic significance of prior alcohol use disorder in patients with presumed metabolic dysfunction‐associated steatotic liver disease: A large multi‐center cohort study

Addiction, EarlyView.
Abstract Background and aims Alcohol use disorder (AUD) follows a chronic, relapsing course but is often overlooked when alcohol consumption is minimal at the time of evaluation. We aimed to assess the prognostic impact of a prior AUD diagnosis on liver‐related outcomes in patients with presumed metabolic dysfunction‐associated steatotic liver disease (
Butros Fakhoury, Jinye Liu, Vinay Jahagirdar, Kaanthi Rama, Gerald Scott Winder, Luis Antonio Díaz, Juan Pablo Arab   +6 more
wiley   +1 more source

Artificial Intelligence and Its Application to Minimal Hepatic Encephalopathy Diagnosis

, 2021
Hepatic encephalopathy (HE) is a brain dysfunction caused by liver insufficiency and/or portosystemic shunting. HE manifests as a spectrum of neurological or psychiatric abnormalities.
Juraj Gazda, Peter Jarcuska, Martin Janicko, Jakub Gazda, Sylvia Drazilova, Peter Drotar, Matej Gazda   +6 more
core   +1 more source

Consensus recommendations on diagnosis and management of posterior reversible encephalopathy syndrome in paediatric haematopoietic stem cell transplantation

British Journal of Haematology, EarlyView.
Summary Posterior reversible encephalopathy syndrome (PRES) is a rare but potentially life‐threatening neurological complication following paediatric allogeneic haematopoietic stem cell transplantation (HSCT). Its heterogeneous presentation and the absence of standardized guidance contribute to variability in diagnosis and management.
Davide Leardini, Luca Bergonzini, Edoardo Muratore, Valentina Pace, Fabiana Cacace, Vanessa Barrui, Anna Fetta, Thomas Foiadelli, Giorgio Costagliola, Luca De Palma, Maria Margherita Mancardi, Stefano Sartori, Francesco Toni, Domenico Tortora, Gaia Alessandra Kullmann, Stefania Giovanna Colafati, Alessandro Orsini, Dario Pruna, Giovanna Lucchini, Francesco Paolo Tambaro, Maura Faraci, Simone Cesaro, Marco Zecca, Angela Mastronuzzi, Riccardo Masetti, Duccio Maria Cordelli   +25 more
wiley   +1 more source

Usefulness of the Stroop test in predicting decompensation events in patients with cirrhosis: A prospective cohort study

Scientific Reports
The Stroop test is used at the point of care to identify covert hepatic encephalopathy (CHE). However, it is unclear whether performance on the Stroop test can predict decompensation in patients with cirrhosis.
Masashi Aiba, Takao Miwa, Sachiyo Hirata, Satomi Nakashima, Kayoko Nishimura, Mikita Oi, Shinji Unome, Kenji Imai, Koji Takai, Masahito Shimizu   +9 more
doaj   +1 more source

Rifaximin ameliorates memory impairment and Alzheimer's pathological changes in APP/PS1 mice associated with changes in the gut microbiome–bile acids–serum metabolites networks

British Journal of Pharmacology, EarlyView.
Background and Purpose Modifying the brain–gut–microbiota axis has emerged as a promising therapeutic strategy against Alzheimer's disease (AD). Whether rifaximin, a non‐absorbed and non‐systemic antibiotic, can be applied to the treatment of AD remains unexplored.
Di Wu, Mei‐Tong Nie, Jixian Lin, Yang Liu, Yong Wang, Min Chu, Lan Zheng, Jing Zhao   +7 more
wiley   +1 more source